Analyst ratings
Across 16 analysts the consensus is a Strong Buy: 16 buy calls against 0 sell, with an average 12-month price target of $60.13.
NASDAQ: DFTX · Biotechnology
Over the past week, Definium Therapeutics (DFTX) saw about 45 mentions across Reddit, X and news, and the read is an Adanos Hold. The crowd averages 48% bullish but is deeply split: News runs 87% bullish while Reddit sits at just 0%. Wall Street is more constructive, with 16 of 16 analysts rating DFTX a buy.
“DFTX shows mixed sentiment without a clear catalyst.”Adanos /explain
Wall Street’s 100% buy share sits next to a crowd that ranges from Reddit at 0% to News at 87%. No other tracker puts the two side by side.
Across 16 analysts the consensus is a Strong Buy: 16 buy calls against 0 sell, with an average 12-month price target of $60.13.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits right on the neutral line, momentum is cooling and the 3 sources disagree sharply, so the read is Hold rather than a clear buy or sell.
Analysts sit 52 points above the crowd average of 48%, the professionals are more constructive than retail. The split is inside the crowd: News reads 87% bullish while Reddit sits at 0%, a 87-point spread that single-source trackers miss.
Over the 30-day window, Definium Therapeutics (DFTX) buzz held subdued around 29.1 while the price drifted down 3.7% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 2.1M shares. Updated Aug 15, 2026. Over the last 7 trading days, DFTX lost 7.6%. Buzz activity in the recent week averaged 35.1 and was variable, swinging between 25.2 and 49.1. Recent volume is running above the 30-day average, suggesting heightened trading interest. Daily crowd sentiment leaned bullish on 11 of the 19 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for DFTX and 2000+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live DFTX sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Aug 15, 2026.
| Adanos signal | Hold |
|---|---|
| Analyst consensus | Strong Buy (16 / 0 / 0) |
| Crowd bullish (7d) | 48% |
| Avg price target | $60.13 |
| Most bullish source | News, 87% |
| Most bearish source | Reddit, 0% |
| Sentiment spread | 87 pts |
| Mentions (7d) | 45 |
| Market cap | $5.73B |
| EPS · Beta | -$3.43 · 2.3 |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Definium Therapeutics (DFTX) currently carries an Adanos hold signal with 61/100 conviction. The current cross-source average reads 48% bullish across 3 active sources. Those sources contribute 45 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Definium Therapeutics (DFTX) is fairly quiet with 16 mentions over the last 7 days; the 30-day context spans 8 tracked subreddits. The 7-day tone is 0% bullish; 3-day activity momentum is falling, suggesting cooling attention.
The crowd reads split on Definium Therapeutics (DFTX), averaging 48% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 87% bullish and Reddit at 0%, a 87-point spread. On the professional side, 16 of 16 analysts rate DFTX a buy.
Of the 16 analysts covering Definium Therapeutics (DFTX), 16 rate it a buy, 0 a hold and 0 a sell, for a strong buy consensus. The average price target is $60.13. That puts the street ahead of the crowd, which averages 48% bullish.
Definium Therapeutics (DFTX)'s cross-source average is mixed at 48% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish. X reads 57% bullish, News reads 87% bullish and reddit coverage is the most negative at 0% bullish. The combined signal points to broad mixed pressure with 61/100 conviction.
The cross-source average is mixed for Definium Therapeutics (DFTX) at 48% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish. The most bearish reading is reddit at 0% bullish. 3-day activity momentum is falling on Reddit and News, while x activity is rising. The hold signal carries 61/100 conviction.
Reddit is the dominant discussion channel with 16 mentions (36% of total volume). News contributes 15 mentions and X contributes 14 mentions. The cross-source average is mixed at 48% bullish, while x is the only source with rising 3-day activity. Source readings are split: 2 sources lean bullish and 1 source leans bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. DFTX's hold signal at 61/100 conviction reflects a mixed cross-source average at 48% bullish. Source readings are split: 2 sources lean bullish and 1 source leans bearish. It is a research shortcut, not financial advice.
The DFTX sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Hold signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key